Literature DB >> 29379191

Genetic cluster of fragile X syndrome in a Colombian district.

Wilmar Saldarriaga1,2,3, Jose Vicente Forero-Forero4,5, Laura Yuriko González-Teshima4,5, Andrés Fandiño-Losada5,6, Carolina Isaza7,5, Jose Rafael Tovar-Cuevas8, Marisol Silva9, Nimrah S Choudhary9, Hiu-Tung Tang9, Sergio Aguilar-Gaxiola10, Randi J Hagerman11,12, Flora Tassone13,14.   

Abstract

BACKGROUND: Fragile X syndrome (FXS) is the most common cause of inherited intellectual disabilities and autism. The reported prevalence of the full mutation (FM) gene FMR1 in the general population is 0.2-0.4 per 1000 males and 0.125-0.4 per 1000 females. Population screening for FMR1 expanded alleles has been performed in newborns and in an adult population. However, it has never been carried out in an entire town. Ricaurte is a Colombian district with 1186 habitants, with a high prevalence of FXS, which was first described by cytogenetic techniques in 1999.
METHODS: Using a PCR-based approach, screening for FXS was performed on blood spot samples obtained from 926 (502 males and 424 females) inhabitants from Ricaurte, accounting for 78% of total population.
RESULTS: A high prevalence of carriers of the expanded allele was observed in all FXS mutation categories. Using the Bayesian methods the carrier frequency of FM was 48.2 (95% Credibility Region CR: 36.3-61.5) per 1000 males and 20.5 (95% CR:13.5-28.6) per 1000 females; the frequency of premutation carrier was 14.1 (95% RC: 8.0-21.7) per 1000 males (95% RC: 8.0-21.7 per 1000 males) and 35.9 (95% RC: 26.5-46.2) per 1000 for females (95% RC: 26.5-46.2 per 1000 females), and gray zone carrier was 13.4 (95% RC: 7.4-20.7) per 1000 males (95% RC: 7.4-20.7 per 1000 males) and 42.2 (95% RC: 32.2-53.8) per 1000 for females (95% RC: 32.2-53.8 per 1000 females). Differences in carrier frequencies were observed for premutation and FM alleles between natives and non-natives.
CONCLUSIONS: This study shows that in Ricaurte the carrier frequencies of FMR1 expanded alleles (premutations and FMs) are higher than those reported in the literature, suggesting that Ricaurte constitutes a genetic cluster of FXS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29379191     DOI: 10.1038/s10038-017-0407-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  26 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  Prevalence of fragile X syndrome.

Authors:  G Turner; T Webb; S Wake; H Robinson
Journal:  Am J Med Genet       Date:  1996-07-12

3.  Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis.

Authors:  Danuta Z Loesch; Richard M Huggins; Quang M Bui; Jennifer L Epstein; Annette K Taylor; Randi Jensen Hagerman
Journal:  J Dev Behav Pediatr       Date:  2002-12       Impact factor: 2.225

Review 4.  Epidemiology of fragile X syndrome: a systematic review and meta-analysis.

Authors:  Jessica Hunter; Oliver Rivero-Arias; Angel Angelov; Edward Kim; Iain Fotheringham; Jose Leal
Journal:  Am J Med Genet A       Date:  2014-04-03       Impact factor: 2.802

5.  Prevalence of the fragile X syndrome among Estonian mentally retarded and the entire children's population.

Authors:  Helen Puusepp; Tiina Kahre; Hiljar Sibul; Viljo Soo; Ilona Lind; Elve Raukas; Katrin Ounap
Journal:  J Child Neurol       Date:  2008-12       Impact factor: 1.987

Review 6.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

7.  Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation.

Authors:  Jane E Roberts; Bridgette L Tonnsen; Lindsay M McCary; Amy L Ford; Robert N Golden; Donald B Bailey
Journal:  Biol Psychiatry       Date:  2015-07-31       Impact factor: 13.382

8.  Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.

Authors:  Bradford Coffee; Krayton Keith; Igor Albizua; Tamika Malone; Julie Mowrey; Stephanie L Sherman; Stephen T Warren
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

Review 9.  The cognitive neuropsychological phenotype of carriers of the FMR1 premutation.

Authors:  Jim Grigsby; Kim Cornish; Darren Hocking; Claudine Kraan; John M Olichney; Susan M Rivera; Andrea Schneider; Stephanie Sherman; Jun Yi Wang; Jin-Chen Yang
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  7 in total

1.  Negotiating political power and stigma around fragile X Syndrome in a rural village in Cameroon: A tale of a royal family and a community.

Authors:  Karen Kengne Kamga; Nchangwi Syntia Munung; Séraphin Nguefack; Ambroise Wonkam; Jantina De Vries
Journal:  Mol Genet Genomic Med       Date:  2021-02-05       Impact factor: 2.473

Review 2.  Fragile X syndrome and fragile X-associated disorders.

Authors:  Akash Rajaratnam; Jasdeep Shergill; Maria Salcedo-Arellano; Wilmar Saldarriaga; Xianlai Duan; Randi Hagerman
Journal:  F1000Res       Date:  2017-12-08

3.  The role of AGG interruptions in the FMR1 gene stability: A survey in ethnic groups with low and high rate of consanguinity.

Authors:  Esther Manor; Raphael Gonen; Benjamin Sarussi; Danielle Keidar-Friedman; Jay Kumar; Hiu-Tung Tang; Flora Tassone
Journal:  Mol Genet Genomic Med       Date:  2019-08-27       Impact factor: 2.183

Review 4.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

5.  Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?

Authors:  Dragana Protic; Maria Jimena Salcedo-Arellano; Maja Stojkovic; Wilmar Saldarriaga; Laura Alejandra Ávila Vidal; Robert M Miller; Nazi Tabatadze; Marina Peric; Randi Hagerman; Dejan B Budimirovic
Journal:  Yale J Biol Med       Date:  2021-12-29

6.  Increased severity of fragile X spectrum disorders in the agricultural community of Ricaurte, Colombia.

Authors:  Wilmar Saldarriaga; María J Salcedo-Arellano; Tatiana Rodriguez-Guerrero; Marcela Ríos; Andrés Fandiño-Losada; Julian Ramirez-Cheyne; Pamela J Lein; Flora Tassone; Randi J Hagerman
Journal:  Int J Dev Neurosci       Date:  2018-10-29       Impact factor: 2.457

7.  Developmental aspects of FXAND in a man with the FMR1 premutation.

Authors:  Ellery Santos; Chinelo Emeka-Nwonovo; Jun Yi Wang; Andrea Schneider; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  Mol Genet Genomic Med       Date:  2020-01-03       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.